Newsroom
Sorted by: Latest
-
Innate et Sobi annoncent l’entrée en vigueur de leur partenariat après réalisation des conditions de clôture
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que le partenariat stratégique précédemment annoncé avec Sobi est désormais en vigueur, à la suite de l’expiration des délais d’attente applicables auprès des autorités de la concurrence et de la réalisation d’autres conditions. Comme annoncé le 10 août 2026, Innate Pharma a conclu un partenariat stratégique avec Sobi pour l’attribution...
-
Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the previously announced strategic partnership with Sobi is now effective following the expiration of applicable antitrust waiting periods and completion of other conditions. As announced on August 10, 2026, Innate Pharma entered a strategic partnership with Sobi to license lacutamab in T-cell lymphoma. Transaction closing triggers the USD 75...
-
Egan-Jones Recommends Shareholders Vote FOR the Garg Group's Proposals on the GREEN Consent Card
NEW YORK--(BUSINESS WIRE)--Vishal Garg, founder and former CEO of Better Home & Finance Corporation (“Better” or the “Company”) (Nasdaq: BETR) and significant stockholder, today announced that leading independent proxy advisory firm, Egan-Jones Proxy Services (“Egan-Jones”), has recommended shareholders vote FOR both of the Garg Group’s proposals on the GREEN consent card, including the removal of five directors on Better’s Board of Directors (the “Board”). Mr. Garg commented: “We appreciat...
-
A Rubedo Life Sciences anuncia estudo clínico para tratar a perda de cabelo com o modulador de GPX4 RLS-1496; primeira evidência humana "ex vivo" demonstra crescimento robusto do folículo piloso
MOUNTAIN VIEW, Califórnia--(BUSINESS WIRE)--A Rubedo Life Sciences, Inc. (Rubedo) anunciou hoje um novo estudo clínico com o composto experimental RLS-1496 em pacientes com alopecia androgenética (AGA), com início previsto para outubro de 2026 e dados iniciais esperados para o primeiro semestre de 2027. O estudo marca a primeira avaliação clínica de um modulador de GPX4 para a perda de cabelo, ampliando o programa que estabeleceu o RLS-1496 como o primeiro modulador de GPX4 do mundo a entrar em...
-
Rebellions وai& تتعاونان لتوفير بنية تحتية موفّرة للطاقة لاستدلال الذكاء الاصطناعي في اليابان
سول، كوريا الجنوبية--(BUSINESS WIRE)--أعلنت Rebellions، الشركة الرائدة عالميًا في مجال البنية التحتية لاستدلال الذكاء الاصطناعي، وai&، شركة عالمية متكاملة رأسيًا في تقنيات الذكاء الاصطناعي، عن شراكة لنشر أنظمة RebelRack من Rebellions ضمن البنية التحتية المتنوعة لموارد الحوسبة لدى ai&، وذلك في إطار خدمة استدلال الذكاء الاصطناعي التي تقدمها الشركة في اليابان. وستتيح هذه الشراكة للشركات والمؤسسات الحكومية والمطورين إمكانية الوصول إلى خدمات استدلال مدعومة بتقنيات Rebellions ومنشورة داخل اليا...
-
Alex Brauer Honored by Lawdragon for Real Estate Work
DALLAS--(BUSINESS WIRE)--Bailey Brauer PLLC co-founder Alex Brauer has been named for a third consecutive year to the Lawdragon 500 Leading Real Estate Lawyers legal guide.Honored attorneys are leaders in the areas of Real Estate development, finance, leasing, REITs, construction, disputes and litigation. Their work, according to Lawdragon, “impacts everyone – from the offices we work in, to our homes, from affordable housing to the most swank Las Vegas resorts.”Mr. Brauer was honored for his ex...
-
Rubedo Life Sciences annonce une étude clinique visant à traiter la chute des cheveux à l’aide du modulateur GPX4 RLS-1496 ; les premiers résultats ex vivo chez l’homme démontrent une croissance robuste des follicules pileux
MOUNTAIN VIEW, Californie--(BUSINESS WIRE)--Rubedo Life Sciences, Inc. (Rubedo) a annoncé aujourd’hui le lancement d’une nouvelle étude clinique sur le RLS-1496, un médicament expérimental, chez des patients atteints d’alopécie androgénétique (AGA), qui débutera en octobre 2026, les premières données étant attendues au cours du premier semestre 2027. Cette étude marque la toute première évaluation clinique d’un modulateur de GPX4 dans le traitement de la chute des cheveux, prolongeant ainsi le...
-
Joybound People & Pets Receives Approval to Move Forward with The Liberty Center
WALNUT CREEK, Calif.--(BUSINESS WIRE)--Joybound People & Pets has received unanimous approval from the Walnut Creek Planning Commission to move forward with construction of The Liberty Center: Pet Boarding, Daycare & Veterinary Behavioral Services, a new community resource designed to provide exceptional everyday care while expanding critical support such as crisis boarding and disaster response for pets and families experiencing hardship. The project was unanimously approved at the Wal...
-
Inauguração do Jayasom Wellness Resort impulsiona visão de bem-estar do AMAALA
RIAD, Arábia Saudita--(BUSINESS WIRE)--Red Sea Global (RSG), a empresa de desenvolvimento de turismo regenerativo, Jayasom Wellness Resort AMAALA, inaugurou uma oferta de saúde holística diferenciada no destino. Projetado pela Heah & Co., com interiores assinados pelo Studio Carter, o Jayasom Wellness Resort AMAALA está localizado na maior enseada de Triple Bay e dispõe de 153 quartos e 24 residências. O resort faz parte do núcleo isolado de bem-estar do AMAALA, na costa do Mar Vermelho, on...
-
BIDU Investors Have Opportunity to Lead Baidu, Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES--(BUSINESS WIRE)--BIDU Investors Have Opportunity to Lead Baidu, Inc. Securities Fraud Lawsuit with SBS Law...